Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Absotrend Q10
- Development stage
- Unknown
- Lead developer
- Primus Remedies
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Absotrend Q10 is a multi-ingredient oral nutraceutical supplement developed and marketed by Primus Remedies. It is formulated as a tablet containing a comprehensive blend of antioxidants, vitamins, minerals, and amino acids, including coenzyme Q10, acetyl-L-carnitine, alpha-lipoic acid, L-arginine, omega-3 fatty acids, lycopene, astaxanthin, piperine, and various essential vitamins and minerals. Absotrend Q10 is designed to support cellular energy production, reduce oxidative stress, promote cardiovascular health, and address nutritional deficiencies.
- Brand names
- Absotrend Q10
- Other names
- Absotrend Q 10Absotrend-Q10Absotrend-Q-10Absotrend-Q 10
02
Targets
NOS1 (nNOS)
Beyond the preview
Go deeper on Absotrend Q10.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Absotrend Q10.